Ming-Kuei Jang - Publications
Affiliations: | Merck, Boston, Boston, MA, United States |
Area:
neurodegenerative diseases; synaptic functions; novel biomarker discoveryYear | Citation | Score | |||
---|---|---|---|---|---|
2015 | Jang M, Um KB, Jang J, Kim HJ, Cho H, Chung S, Park MK. Coexistence of glutamatergic spine synapses and shaft synapses in substantia nigra dopamine neurons. Scientific Reports. 5: 14773. PMID 26435058 DOI: 10.1038/srep14773 | 0.3 | |||
2013 | Kostakis E, Smith C, Jang MK, Martin SC, Richards KG, Russek SJ, Gibbs TT, Farb DH. The neuroactive steroid pregnenolone sulfate stimulates trafficking of functional N-methyl D-aspartate receptors to the cell surface via a noncanonical, G protein, and Ca2+-dependent mechanism. Molecular Pharmacology. 84: 261-74. PMID 23716622 DOI: 10.1124/Mol.113.085696 | 0.56 | |||
2011 | Kostakis E, Jang MK, Russek SJ, Gibbs TT, Farb DH. A steroid modulatory domain in NR2A collaborates with NR1 exon-5 to control NMDAR modulation by pregnenolone sulfate and protons. Journal of Neurochemistry. 119: 486-96. PMID 21883211 DOI: 10.1111/J.1471-4159.2011.07442.X | 0.562 | |||
2004 | Jang MK, Mierke DF, Russek SJ, Farb DH. A steroid modulatory domain on NR2B controls N-methyl-D-aspartate receptor proton sensitivity. Proceedings of the National Academy of Sciences of the United States of America. 101: 8198-203. PMID 15150412 DOI: 10.1073/Pnas.0401838101 | 0.733 | |||
Show low-probability matches. |